Vitro Diagnostics Inc (fka VODG)

[TomFromYahoo]

Partner news... (link below). This is a bit obscure, but it is a good sign. It's a press release from a vendor about a product that VB will be using in the Pitt Hopkins trial. It indicates a few things to me, namely (1) they are preparing to move ahead with the trial soon, and are assuming that the money from the IPO will be in place to fund it, (2) stuff like this is what makes clinical trials expensive to conduct, and (3) they are making every attempt to eliminate all chances of adverse reactions.

Regarding (3), I suspect they have chosen an extremely obscure disease like Pitt Hopkins for this study because it was easier to get approval for an orphan disease (one with no known treatments), not because they necessarily expect positive results. And this one is necessarily limited in scope, since there aren't that many people who have the disease. That and this press release suggest to me that what they're really after in this particular trial is to establish safety, not (necessarily) efficacy. If they can establish safety in a domestic, FDA-sanctioned trial, it's a huge step forward because they won't need to go through such hoops in other trials. So they are spending money to eliminate as many variables as they can. Just one person's uninformed take.

Partner Press Release